March 30, 2023

Recap AMCP 2023: Our thought leadership in action

By Xcenda

From delivering a repeat training on developing a comprehensive HCEI strategy to incorporating value framework assessments in coverage discussions to award-winning research, AmerisourceBergen was a proud supporter of this year's conference.

Explore some of our expert contributions, media coverage, and related content that showcased our commitment to helping our biopharma partners accelerate product success.

Media coverage

FormularyWatch

Payers want value from pharma specialty programs, surveys find

Read article

The American Journal of Managed Care^®

AMCP 2023 will cover biosimilars, Inflation Reduction Act, and much more, says Kimberly Westrich

Watch video

Managed Healthcare Executive^®

Incorporating value framework sssessments in coverage and reimbursement decisions, per Kimberly Westrich

Watch video

Managed Healthcare Executive^®

It's not just the P&T Committee. Payers are putting value assessment committees, filters on drug coverage decisions

Read article

Award-winning research

AMCP bronze medal award

Analysis of pharmacy benefit manager formulary exclusions in oncology

View poster

Interactive digital poster

The utilization of natural language processing (NLP) to gauge healthcare decision-maker perceptions of cell and gene therapies (CGTs)

View digital poster

US payer perceptions of innovative contracts with cell and gene therapies

Trends in Payer Uptake and Perceptions of the Institute for Clinical and Economic Review Value Assessment Framework From 2016 to 2022

Payer perceptions on incentives and barriers to innovative partnerships between biopharmaceutical manufacturers and payer organizations

Preliminary evaluation of perceptions surrounding biosimilar landscape, uptake and adoption among pediatric hospitals and health systems in the United States

Abstract photography showing blue and white lines with a sense of motion

Insight

Optimize your pre-approval information exchange strategy

Charles Dragovich
Xcenda
March 2023

Waves of lines in AmerisourceBergen true blue

Insight

Closing the gaps in pre-approval information exchange to accelerate product success and patient access

Xcenda
August 2022

Learn more

Insight

Why FormularyDecisions^® is the right choice for enterprise biopharma payer engagement

Xcenda
July 2022

Learn more

FormularyDecisions^®

For biopharma

Did you miss our lunch and learn for biopharma companies at AMCP 2023? You can still connect with our team to learn how you can connect with the largest active online payer community in the US to share information throughout your product's lifecycle.

Request a demo

For healthcare decision makers

Didn't get a chance to stop by for bubble tea break at AMCP 2023 but still want to access evidence for thousands of products - all from one site? Register today and start streamlining your formulary review process.

Innovation and Impact Award

As healthcare decision makers strive to make informed choices about medication use and improve health outcomes, they rely on various types of information. In today's digital age, these decision makers increasingly depend on digital channels to access product-related information.

The inaugural Innovation and Impact Award was awarded to two biopharma companies who have gone above and beyond in their innovation of digital healthcare decision maker engagement. Congratulations to Phathom Pharmaceuticals and AbbVie Inc.

Stay on top of the latest US health policy news

Stay informed with Health Policy Weekly, an at-a-glance view of legislative and regulatory developments and news that impacts the healthcare industry

Subscribe today

Topics: